Summary.-Sera were collected from patients with acute myelogenous leukaemia (AML) at various times during remission induced by chemotherapy, but after cessation of all immunosuppressive treatment. These sera were tested, by a sensitive assay using radio-labelled antiglobulin binding, for the presence of antibodies which bound to the surface of autologous AML cells. The cell populations examined were chosen on the basis that they proliferated in short-term culture, did not bind anti-Ig reagents directly, and that more than 80% of the cells did not carry detectable Fc receptors. With 8/9 patients studied, no specific antibodies of the IgG or IgM class could be detected in serum samples taken during remission. IgG and IgM antibodies from the remission sera of one patient were found to bind to autologous leukaemic cells, but this was found to be due to the presence of rheumatoid factor (RF) and removal of the RF activity abolished this binding.
with human acute myelogenous leukaemia (AML) has been adduced from the finding that lymphocytes taken from patients in remission are stimulated into DNA synthesis in co-culture with autologous leukaemic cells (Fridman & Kourilsky, 1969; Anderson et al., 1974; Cocks et al., 1977) . The interpretation of the data obtained in these experiments, however, has been complicated by the discovery that under some conditions B cells from normal healthy individuals can stimulate their autologous T cells (Opelz et al., 1975; Bergholtz et at., 1977) and by the failure to find, in patients during remission, lymphocytes that are cytotoxic for autologous leukaemic cells (Hopkins & Alexander, unpublished) . Moreover, attempts to detect, during remission, serum antibodies that are cytotoxic to autologous AML cells, either with complement or in a cell-dependent-antibody assay, have been unsuccessful (Gale & MacLennan, 1977; Chapuis et al., 1978) .
The present investigation set out to determine whether non-lytic autologous antibodies could be detected in remission sera, by a sensitive assay using radiolabelled-antiglobulin binding, which we find to be more sensitive than complementdependent cytotoxicity for the detection of alloantibodies (anti-HLA) on (Chapuis et al., 1977) and for which remission sera were available, 9 fulfilled the above criteria.
MATERIALS AND METHODS
Leukaemic cells.-AML cells cryopreserved by the method of Chapuis et al. (1977) were thawed rapidly at 37°C, diluted slowly with RPM1 1640 medium, spun down at 400 g for 5 min, washed twice with the medium, and finally resuspended at a concentration of 3 x 106/ml in medium supplemented with 15% foetal calf serum (FCS), 100 u/ml penicillin, 100 u/ml streptomycin and 300 jug/ml IgM were prepared by standard procedures from either pooled normal serum or myeloma serum (Fahey & Terry, 1979) and then coupled to CNBr-activated Sepharose-4B (Pharmacia Fine Chemicals, Uppsala, Sweden).
Sheep antibodies to human IgG and rabbit antibodies to human IgM, which had been absorbed first to remove unwanted specificities, were then adsorbed to the respective affinity column. After washing with phosphate-buffered saline (PBS), pH 7-4, containing lM NaCl, the specific antibodies were eluted with 3M KSCN and dialysed extensively against PBS containing 0.02% NaN3.
The affinity-purified antibodies were labelled with 1 25lodine according to the method of McConahey & Dixon (1966) to a specific activity of 1-5 ,tCi/tg of protein.
Absorption of AML sera with cultured AML cells.-200,1t aliquots of AML sera (diluted 1: 2 with medium) were incubated with 2 x 107 autologous or allogeneic cultured AML cells for 16 h at 4°C. The cells were centrifuged down and the absorbed serum removed.
Rheumatoid Factor (RF).-Serum samples were tested for RF by latex agglutination (Latex-RF Reagent, Hoechst Pharmaceuticals, Hounslow, Middlesex).
(a) Absorption of RF from AML sera on aggregated human IgG: human IgG, aggregated by heating at 63TC for 30 min, was linked to CNBr-activated Sepharose-4B to give a final concentration of about 5 mg protein/ml of gel.
A 200,iu packed volume of Sepharoseaggregated IgG was mixed with an equal volume of AML serum diluted 1:2 with medium+ 10% FCS and rotated overnight at 4°C. After centrifugation the absorbed serum was removed and retested for RF by latex agglutination, and for binding to autologous cultured AML cells.
(b) Purification of RF: 30 ml of plasma obtained from a patient with rheumatoid arthritis (RF titre 1:320) was diluted 1:5 with PBS-azide and decomplemented by heating at 56°C for 30 min. The RF was adsorbed to a column of Sepharose-aggregated human IgG, then after washing with PBS containing IM NaCl, the RF was eluted with 3M KSCN and dialysed against PBSazide. The RF obtained (5-7 mg protein in 15 ml) had an agglutination titre of 1:80. Whilst the principal protein in this preparation was IgM, some IgG (< 10% of total protein) could be detected by double-diffusion analysis (Ouchterlony, 1948 
RESULTS
Sera from 9 AMIL patients, taken at various times during remission, were examined for the presence of antibodies binding to the plasma membrane of cultured autologous leukaemic cells. The negative control was normal AB serum (NHS) and the positive control polyspecific anti-HLA sertum. (Table I) in whom the apparent levels of IgG antibody rose during the first 5 months in remission and then fell. High levels of IgM were also found in remission sera, and these levels fell only when the patient relapsed (Figure) .
Three of the high-binding sera from Patient C.L. were pooled (Pool A) as were 3 of the low-binding sera (Pool B) and examined for specificity by absorption on the patient's own cultured AML cells, and for cross-reactivity by absorption on 4 allogeneic cultured AML cell populations (Table II) . Absorption of the pooled sera The patients' sera were tested for RF and all those collected from the first 8 patients were negative by latex agglutination. All sera from Patients C.L., however, (Table III) . This indicates that some or all of the antiIgG and anti-IgM binding was due to the presence of RF in the sera. To distinguish between the possibilities (a) that the RF bound to IgG antibodies that had complexed with cell-surface antigens and so "amplified" the binding of autologous antibody, or (b) that the cultured AML cells possessed receptors for RF; the binding of purified RF to 3 different populations of cultured AML cells was determined (Table IV) . When these cells were treated with the anti-HLA serum before exposure to RF, the quantity of 1251 antiIgM bound subsequently was greater than in cells treated with just RF. Only a small effect was seen when the normal AB serum had been used. All 3 cell populations were then examined for RF binding et al. (1979) have also shown that RF in the sera from melanoma patients interferes with tests for cell-bound antibody.
The patients examined in the present study were treated initially with intensive chemotherapy, until they became clinically disease-free. While in remission they received no immunosuppressive therapy, and the only treatment was inoculation with BCG and irradiated allogeneic leukaemic cells (Powles, 1973) . It has been shown that during this time the patients' lymphocytes react normally in the mixedlymphocyte reaction (Cocks et al., 1977) and cytotoxic alloantibodies could be detected in remission sera after challenge with allogeneic leukaemic cells (Chapuis et al., 1978) . Accordingly, the failure to detect antibodies to autologous leukaemic cells cannot be attributed to immunosuppressive treatment.
